Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / May / ChatGPT Sits Its Exams
Research & Innovations

ChatGPT Sits Its Exams

Study that ChatGPT shows promise in ophthalmology-based MCQs, but falls short on clinical reasoning

By The Ophthalmologist 5/8/2025 3 min read

Share

0525-004-AI-News-ChatGPT-sits-its-exams.png

A study published in Vision has tested the capabilities of ChatGPT models against human candidates sitting the European Board of Ophthalmology Diploma (EBOD) examination, and the results reveal both promise and limitations for artificial intelligence (AI) in medical education.

Researchers evaluated ChatGPT-3.5 Turbo and ChatGPT-4o using over 2,200 true/false statements and 48 single best answer (SBA) questions sourced from actual EBOD exams held between 2012 and 2023. ChatGPT-4o achieved an impressive 80.4 percent accuracy on multiple-choice questions (MCQs), surpassing the pass mark and performing comparably to human candidates. In contrast, ChatGPT-3.5 scored 63.2 percent, slightly below the typical passing threshold. Both models showed strongest performance in text-based pathology and retina-related questions, with weaker results in optics and refraction.

However, AI's performance dropped dramatically on SBA questions. ChatGPT-3.5 scored just 28.4 percent accuracy, with ChatGPT-4o coming in slightly lower at 24.1 percent, both significantly underperforming compared to the average candidate. These SBA questions often require higher-order clinical reasoning and the ability to discriminate between closely related options, skills that current AI models struggle to replicate.

Interestingly, ChatGPT-4o answered all the easiest MCQs correctly but fared worse than ChatGPT-3.5 on the most challenging ones. This highlights a trade-off: newer models may excel in general knowledge, but they are not necessarily better at complex, ambiguous reasoning.

The study suggests that while ChatGPT is capable of retrieving and interpreting structured knowledge, its integration of nuanced clinical judgment still remains limited. The authors conclude that while ChatGPT is not yet ready to replace human judgment in high-stakes medical assessments, rapid advancements in large language models suggest that its role in ophthalmic education will continue to expand in the future.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: